Table S1 from Competitive Kinase Enrichment Proteomics Reveals that Abemaciclib Inhibits GSK3β and Activates WNT Signaling

MLA

Michael B. Major, et al. Table S1 from Competitive Kinase Enrichment Proteomics Reveals That Abemaciclib Inhibits GSK3β and Activates WNT Signaling. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1541-7786.22513254.v1.

APA

Michael B. Major, Gary L. Johnson, David Darr, Jose Roques, Feng Yan, Dennis Goldfarb, & Emily M. Cousins. (2023). Table S1 from Competitive Kinase Enrichment Proteomics Reveals that Abemaciclib Inhibits GSK3β and Activates WNT Signaling. https://doi.org/10.1158/1541-7786.22513254.v1

Chicago

Michael B. Major, Gary L. Johnson, David Darr, Jose Roques, Feng Yan, Dennis Goldfarb, and Emily M. Cousins. 2023. “Table S1 from Competitive Kinase Enrichment Proteomics Reveals That Abemaciclib Inhibits GSK3β and Activates WNT Signaling,” April. doi:10.1158/1541-7786.22513254.v1.